Clinical trial
HALT Progression of Polycystic Kidney Disease Study A
NCT00283686 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00283686 |
|---|---|
| Title | HALT Progression of Polycystic Kidney Disease Study A |
| Official title | HALT Progression of Polycystic Kidney Disease Study A |
| Acronym | HALT PKD A |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Boehringer Ingelheim Industry Merck Sharp & Dohme LLC Polycystic Kidney Disease Foundation University of Pittsburgh Washington University School of Medicine |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney, Polycystic |
| Intervention type | Drug, Other |
| Interventions | Lisinopril, Telmisartan, Placebo, Standard Blood Pressure Control, Low Blood Pressure Control |
| Enrollment | 558 |
| Start date | Jan 1, 2006 |
| Primary completion | Jun 1, 2014 |
| Completion | Jun 1, 2014 |
| First posted | Jan 30, 2006 |
| Last update posted | Apr 21, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: